Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Levels of CEA and Ca 19 - 9 in the sera and peritoneal cavity in patients with gastric and pancreatic cancers.

Hoskovec D, Varga J, Konečná E, Antos F.

Acta Cir Bras. 2012 Jun;27(6):410-6.

2.

Levels of carcinoembryonic antigen and CA 19-9 in the sera and peritoneal washing of patients undergoing surgical treatment for gastric carcinoma.

Crepaldi-Filho R, Palma RT, Giusti MF, Bueno Mde A, Silva PS, Waisberg J.

Arq Gastroenterol. 2008 Jul-Sep;45(3):219-24.

3.

Risk factors for peritoneal dissemination of gastric cancer.

Yeldan E, Oguz S, Usta U, Ilhan E, Senlikci A.

Minerva Chir. 2015 Apr;70(2):91-6.

PMID:
25815699
4.

Prognostic significance of tumor markers in peritoneal lavage in advanced gastric cancer.

Yamamoto M, Baba H, Kakeji Y, Endo K, Ikeda Y, Toh Y, Kohnoe S, Okamura T, Maehara Y.

Oncology. 2004;67(1):19-26.

PMID:
15459491
5.

Carcinoembryonic antigen levels in the peritoneal cavity: useful guide to peritoneal recurrence and prognosis for gastric cancer.

Nishiyama M, Takashima I, Tanaka T, Yoshida K, Toge T, Nagata N, Iwamori S, Tamura Y.

World J Surg. 1995 Jan-Feb;19(1):133-7; discussion 137.

PMID:
7740800
6.

Clinical significance of carcinoembryonic antigen in peritoneal lavage from patients with gastric cancer.

Kanetaka K, Ito S, Susumu S, Yoneda A, Fujita F, Takatsuki M, Kuroki T, Eguchi S.

Surgery. 2013 Sep;154(3):563-72. doi: 10.1016/j.surg.2013.03.005. Epub 2013 Jun 24.

PMID:
23806263
7.

An elevated preoperative serum carbohydrate antigen 19-9 level is a significant predictor for peritoneal dissemination and poor survival in colorectal cancer.

Takakura Y, Ikeda S, Imaoka Y, Urushihara T, Itamoto T.

Colorectal Dis. 2015 May;17(5):417-25. doi: 10.1111/codi.12865.

PMID:
25512077
8.

Prognostic value of CEA and CA 19-9 tumor markers combined with cytology from peritoneal fluid in colorectal cancer.

Lee IK, Kim DH, Gorden DL, Lee YS, Sung NY, Park GS, Kim HJ, Kang WK, Park JK, Ahn CH, Kim JG, Jeon HM, Oh ST.

Ann Surg Oncol. 2009 Apr;16(4):861-70. doi: 10.1245/s10434-008-0294-3. Epub 2009 Feb 3.

PMID:
19189191
9.

Comparison of CA 72-4, CA 19-9 and CEA in the diagnosis and monitoring of gastric cancer.

Safi F, Kuhns V, Beger HG.

Int J Biol Markers. 1995 Apr-Jun;10(2):100-6.

PMID:
7561233
10.

[CA72-4 and CEA in serum and peritoneal washing in gastric cancer].

Mandorwski S, Lourenço LG, Forones NM.

Arq Gastroenterol. 2002 Jan-Mar;39(1):17-21. Portuguese.

PMID:
12184160
11.

Detection of cancer cells and gene expression of cytokines in the peritoneal cavity in patients with gastric cancer.

Fukumoto Y, Ikeguchi M, Matsumoto S, Inoue M, Osaki T, Fukuda K, Saito H, Tatebe S, Tsujitani S.

Gastric Cancer. 2006;9(4):271-6. Epub 2006 Nov 24.

PMID:
17235628
12.
13.

An endogastric capsule for measuring tumor markers in gastric juice: an evaluation of the safety and efficacy of a new diagnostic tool.

Muretto P, Graziano F, Staccioli MP, Barbanti I, Bartolucci A, Paolini G, Giordano D, Testa E, De Gaetano A.

Ann Oncol. 2003 Jan;14(1):105-9.

PMID:
12488301
14.

Intraoperative lavage for cytological examination in 1,297 patients with gastric carcinoma.

Bando E, Yonemura Y, Takeshita Y, Taniguchi K, Yasui T, Yoshimitsu Y, Fushida S, Fujimura T, Nishimura G, Miwa K.

Am J Surg. 1999 Sep;178(3):256-62.

PMID:
10527450
15.

Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer.

Jiexian J, Xiaoqin X, Lili D, Baoguo T, Ting S, Xianwen Z, Cunzhi H.

Int J Biol Markers. 2013 Jun 28;28(2):192-200. doi: 10.5301/jbm.5000023.

PMID:
23787496
16.

[Immunocytologic detection of disseminated tumor cells in the peritoneal cavity and bone marrow in patients with pancreatic carcinoma].

Juhl H, Kalthoff H, Krüger U, Schott A, Schreiber HW, Henne-Bruns D, Kremer B.

Chirurg. 1994 Dec;65(12):1111-5. German.

PMID:
7851144
17.

Carcinoembryonic antigen level in peritoneal washing is a prognostic factor in patients with gastric cancer.

Irinoda T, Terashima M, Takagane A, Sasaki N, Abe K, Araya M, Nishizuka S, Yonezawa H, Nakaya T, Shimooki O, Oyama K, Ikeda K, Saito K.

Oncol Rep. 1998 May-Jun;5(3):661-6.

PMID:
9538172
18.
19.

Preoperative positivity of serum tumor markers is a strong predictor of hematogenous recurrence of gastric cancer.

Marrelli D, Pinto E, De Stefano A, de Manzoni G, Farnetani M, Garosi L, Roviello F.

J Surg Oncol. 2001 Dec;78(4):253-8.

PMID:
11745820
20.

The characteristics of the serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels in gastric cancer cases.

Wada N, Kurokawa Y, Miyazaki Y, Makino T, Takahashi T, Yamasaki M, Nakajima K, Takiguchi S, Mori M, Doki Y.

Surg Today. 2017 Feb;47(2):227-232. doi: 10.1007/s00595-016-1408-3. Epub 2016 Aug 26.

PMID:
27566604

Supplemental Content

Support Center